Evaluation of correlation between serum and salivary fibronectin in myocardial infarction patients in Samarra city/ Iraq
DOI:
https://doi.org/10.54153/sjpas.2021.v3i1.178Keywords:
الفايبرونكتين، امراض القلب، احتشاء العضلة القلبيةAbstract
This study conducted on 50 patients 18 of them are females and 32 are males their ages ranged between40-73 years diagnosed as myocardial infarction patients in Samara general hospital in Samarra city for the period between 1/9/2019 to 9/6/2020 compared to 25 apparently healthy people as a control group. Serum fibronectin was significantly higher (P≤ 0.05) in patients (5.771±1.461) compared to control (0.374±0.089) ng/ml. Salivary fibronectin was significantly lower (P≤ 0.05) in patients (0.424) compared to control (9.775) ng/ml.Total cholesterol, TG, LDL-c was significantly higher (P≤ 0.05) in patients (230.62±34.989), (217.60±39.894 ، ((152.34±35.319 (compared to control (169.20±21.136), ( 132.92±32.058 69.04±10.510 ( mg/dl respectively. There is positive correlation between serum and salivary fibronectin in patients with MI and between serum fibronectin and serum total cholesterol,There is significantly correlation between serum and TG and LDL-c in control .
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Samarra Journal of Pure and Applied Science
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright Notice
Authors retain copyright and grant the SJPAS journal right of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in Samarra Journal of Pure and Applied Science.
The Samarra Journal of Pure and Applied Science permits and encourages authors to archive Pre-print and Post-print items submitted to the journal on personal websites or institutional repositories per the author's choice while providing bibliographic details that credit their submission, and publication in this journal. This includes the archiving of a submitted version, an accepted version, or a published version without any Risks.
